Tollegno, Italy

Silvia Costa

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Piemonte Orientale. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Silvia Costa. Retrieved from https://idiyas.com/inventor/silvia-costa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Silvia Costa - Innovator in Therapeutic Agents

Introduction

Silvia Costa is a prominent inventor based in Tollegno, Italy. She has made significant contributions to the field of therapeutic agents, particularly in the treatment of autoimmune and inflammatory disorders. Her innovative work has garnered attention in the scientific community.

Latest Patents

Silvia holds a patent for "Extracellular IFI16 as therapeutic agents." This invention focuses on the inhibition of the circulating extracellular form of the interferon-inducible protein 16 (extracellular IFI16) for treating various diseases, especially autoimmune and inflammatory disorders or infective disorders. This patent represents a crucial advancement in therapeutic strategies.

Career Highlights

Silvia Costa is affiliated with the University of Piemonte Orientale, where she conducts her research and development. Her work has been instrumental in exploring new therapeutic avenues and enhancing the understanding of disease mechanisms.

Collaborations

Silvia collaborates with esteemed colleagues, including Michele Mondini and Marisa Gariglio. These partnerships have enriched her research and contributed to the advancement of knowledge in her field.

Conclusion

Silvia Costa is a dedicated inventor whose work in therapeutic agents is paving the way for innovative treatments. Her contributions are vital in addressing complex health challenges, and her ongoing research promises to yield further advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…